GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 203 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q2 2018. The put-call ratio across all filers is 0.35 and the average weighting 0.3%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $324,000 | +39.1% | 4,754 | +4.6% | 0.00% | 0.0% |
| Q1 2020 | $233,000 | -46.4% | 4,543 | -17.0% | 0.00% | 0.0% |
| Q4 2019 | $435,000 | +75.4% | 5,473 | +7.4% | 0.00% | – |
| Q3 2019 | $248,000 | -17.3% | 5,096 | -10.6% | 0.00% | – |
| Q2 2019 | $300,000 | +11.9% | 5,698 | +12.5% | 0.00% | – |
| Q1 2019 | $268,000 | +22.4% | 5,063 | -4.9% | 0.00% | – |
| Q4 2018 | $219,000 | 0.0% | 5,324 | +9.7% | 0.00% | – |
| Q2 2018 | $219,000 | -93.0% | 4,853 | -93.7% | 0.00% | -100.0% |
| Q4 2017 | $3,144,000 | -13.4% | 77,358 | -33.8% | 0.00% | -20.0% |
| Q3 2017 | $3,629,000 | +20.6% | 116,895 | +6.3% | 0.01% | +25.0% |
| Q2 2017 | $3,008,000 | +8.5% | 109,995 | +46.2% | 0.00% | 0.0% |
| Q1 2017 | $2,773,000 | -35.6% | 75,246 | -74.8% | 0.00% | -42.9% |
| Q4 2016 | $4,308,000 | +43.2% | 298,176 | +128.4% | 0.01% | +40.0% |
| Q3 2016 | $3,009,000 | – | 130,525 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HUNTINGTON NATIONAL BANK | 1 | $68 | 0.00% |